Healthcare Headlines

GSK's new CEO aims to divest sports nutrition brand: sources

GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday.

Bain, Cinven collect 41.4 percent of Stada shares

Buyout groups Bain Capital and Cinven have been offered just over 41 percent of the shares in German drugmaker Stada , 26 points short of the required minimum, the private equity groups said on Wednesday, one day before the offer period expires.